Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.Unusual Whales·Sep 15 at 12:04 PMGSK-1.38%SGIOY+0.17%
Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Grows By 797.8%Market Beat·Sep 11 at 01:20 AMSGIOY+0.17%4507
Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest UpdateMarket Beat·Aug 29 at 01:00 PMSGIOY+0.17%4507
Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Decreases By 84.4%Market Beat·Aug 12 at 09:00 AMSGIOY+0.17%4507
Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Increases By 279.3%Market Beat·Jul 26 at 02:20 PMSGIOY+0.17%4507
FDA accepts Shionogi sNDA for Fetroja pediatric use in serious Gram-negative infectionsPUBT·Jul 16 at 12:31 PMSGIOY+0.17%4507
Shionogi & Co: Strong ROE and growth-focused strategies drive value, supported by robust governance and IRQuartr·Jun 24 at 07:57 AM4507SGIOY+0.17%
Is First-in-Class FDA Approval For XOCOVA PEP Altering The Investment Case For Shionogi (TSE:4507)?Simplywall·Jun 8 at 09:33 AM4507SGIOY+0.17%
<![CDATA[FDA Approves Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy]]>Pharmexec·Jun 1 at 02:14 PM4507SGIOY+0.17%
